Cardiovascular Center and Health Management Center, National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Taiwan.
Atherosclerosis. 2011 May;216(1):226-36. doi: 10.1016/j.atherosclerosis.2011.01.046. Epub 2011 Mar 2.
The objective was to evaluate the association of a panel of renal biomarkers with long-term mortalities.
Participants in the Third National Health and Nutrition Examination Survey (NHANES III) aged 35 years and above were included and Framingham risk scores were calculated. Renal-related biomarkers, including creatinine-based estimated glomerular filtration rate (eGFR), cystatin C, uric acid, C-reactive protein (CRP), fibrinogen, urinary cadmium, albuminuria, homocysteine, and vitamin D were tested by Cox-regression model for their association with all-cause, cardiovascular (CV), and non-CV mortality obtained from the 2006 NHANES III-linked follow-up data, stratified by sex and Framingham risk.
In the 4873 men and 5372 women, 36.3%, 28.1%, and 35.6% of men and 67.2%, 25.8%, and 7.0% of women were classified into low-, intermediate-, and high coronary risk groups. With an average follow-up of 13.2 years, a total of 3632 deaths and 1657 CV deaths were recorded. Albuminuria was associated with all-cause mortality in both sexes across coronary risk groups. Creatinine-based eGFR provided additional differential capacity only in the women with intermediate-to-high coronary risk. Cystatin C was associated with all-cause mortality in the men with intermediate-to-high coronary risk and with CV mortality in the women with low coronary risk. Urinary cadmium was positively related to non-CV mortality. High vitamin D was protective against cardiovascular mortality in a limited category of men and women.
Albuminuria is associated with long-term all-cause mortalities independent of Framingham risks. Adding the panel of renal biomarkers provides limited advantages for predicting risk when compared to FRS alone.
评估一组肾脏生物标志物与长期死亡率的关联。
纳入参加第三次全国健康和营养调查(NHANES III)且年龄在 35 岁及以上的参与者,并计算弗雷明汉风险评分。通过 Cox 回归模型,对肾脏相关生物标志物(包括基于肌酐的估算肾小球滤过率[eGFR]、胱抑素 C、尿酸、C 反应蛋白[CRP]、纤维蛋白原、尿镉、白蛋白尿、同型半胱氨酸和维生素 D)进行检验,以评估其与 2006 年 NHANES III 相关随访数据中获得的全因、心血管(CV)和非 CV 死亡率的关联,这些数据按性别和弗雷明汉风险进行分层。
在 4873 名男性和 5372 名女性中,36.3%、28.1%和 35.6%的男性和 67.2%、25.8%和 7.0%的女性分别被归入低、中、高冠心病风险组。平均随访 13.2 年后,共记录到 3632 例死亡和 1657 例 CV 死亡。白蛋白尿与各冠心病风险组中男性和女性的全因死亡率均相关。基于肌酐的 eGFR 仅在具有中至高冠心病风险的女性中提供了额外的差异能力。胱抑素 C 与具有中至高冠心病风险的男性的全因死亡率相关,与低冠心病风险的女性的 CV 死亡率相关。尿镉与非 CV 死亡率呈正相关。高维生素 D 对有限类别的男性和女性的心血管死亡率具有保护作用。
白蛋白尿与独立于弗雷明汉风险的长期全因死亡率相关。与单独使用 FRS 相比,添加肾脏生物标志物组提供了有限的预测风险优势。